Research Topics
| Steven ItzkowitzSummaryAffiliation: Mount Sinai School of Medicine Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Diagnosis and management of dysplasia in patients with inflammatory bowel diseasesSteven H Itzkowitz
The Dr Henry D Janowitz Division of Gastroenterology, Department of Medicine, The Mount Sinai School of Medicine, New York, New York 10029, USA
Gastroenterology 126:1634-48. 2004..The clinical application of newer molecular methods to detect neoplasia, particularly gene microarrays and stool DNA testing, also deserve further study...
Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel diseaseSteven H Itzkowitz
Division of Gastroenterology, Department of Medicine, The Mount Sinai School of Medicine, New York, New York, USA
Inflamm Bowel Dis 11:314-21. 2005..A panel of international experts was assembled to develop consensus recommendations for the performance of surveillance. The findings are presented herein...
Polypoid dysplasia in inflammatory bowel disease: removing the bumps in the roadSteven Itzkowitz
Mount Sinai School of Medicine, New York City, NY 10029, USA
Inflamm Bowel Dis 12:919-20. 2006
Improved fecal DNA test for colorectal cancer screeningSteven H Itzkowitz
Department of Medicine and Oncological Sciences, Mount Sinai School of Medicine, New York, New York 10029, USA
Clin Gastroenterol Hepatol 5:111-7. 2007..The present study was conducted to determine the sensitivity and specificity of a second-generation assay (version 2) that uses improved DNA stabilization/isolation techniques and a new promoter methylation marker...
Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammationSteven H Itzkowitz
Gastrointestinal Division, Box 1069, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA
Am J Physiol Gastrointest Liver Physiol 287:G7-17. 2004..Mice genetically prone to inflammatory bowel disease also develop colorectal cancer especially in the presence of bacterial colonization. These observations offer compelling support for the role of inflammation in colon carcinogenesis...
Molecular biology of dysplasia and cancer in inflammatory bowel diseaseSteven H Itzkowitz
The Dr Henry D Janowitz Division of Gastroenterology, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA
Gastroenterol Clin North Am 35:553-71. 2006..Although none of the molecular alterations to be discussed have yet been integrated into clinical practice, there is potential for molecular diagnostics to enhance the management of patients with long-standing IBD...
Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practiceSteven Itzkowitz
Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA
J Clin Gastroenterol 36:S70-4; discussion S94-6. 2003..It will be important to study whether these markers, or other panels of gene or protein expression, can identify patients at highest risk for developing CRC in future clinical studies...
Cancer prevention in patients with inflammatory bowel diseaseSteven H Itzkowitz
Dr Henry D Janowitz Division of Gastroenterology, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA
Gastroenterol Clin North Am 31:1133-44. 2002..Future research will help to define better the natural history of dysplasia in IBD, and to determine how molecular approaches may be integrated into surveillance programs to reduce CRC risk...
Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamineThomas Ullman
Dr Henry D Janowitz Division of Gastroenterology, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA
Clin Gastroenterol Hepatol 6:1225-30; quiz 1177. 2008..The aim of this study was to compare rates of progression with advanced neoplasia in patient cohorts with UC taking low and high doses of mesalamine and to determine where in the process of neoplastic progression mesalamine might act...
A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minoritiesJennifer Christie
Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA
J Natl Med Assoc 100:278-84. 2008..A PN improves compliance with screening colonoscopy in low-income minorities. Larger studies are needed to evaluate what features of navigation are most effective in facilitating completion of screening colonoscopy...
A simplified, noninvasive stool DNA test for colorectal cancer detectionSteven Itzkowitz
Department of Medicine and Oncological Sciences, Mount Sinai School of Medicine, New York, New York 10029, USA
Am J Gastroenterol 103:2862-70. 2008....
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort studyRoopali Bansal Gupta
Department of Medicine, The University of Texas Southwestern, Dallas, Texas, USA
Gastroenterology 133:1099-105; quiz 1340-1. 2007..Our aim was to determine whether severity of microscopic inflammation over time is an independent risk factor for neoplastic progression in UC...
Trefoil factor-3 expression in human colon cancer liver metastasisMark Babyatsky
The Dr Henry D Janowitz Division of Gastroenterology, Department of Medicine, The Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1069, New York, NY 10029 6574, USA
Clin Exp Metastasis 26:143-51. 2009..These results provide further evidence that TFF3 contributes to the malignant behavior of colon cancer cells. These observations may have relevance for designing new diagnostic and treatment approaches to colorectal cancer...
A program to enhance completion of screening colonoscopy among urban minoritiesLea Ann Chen
Division of Gastroenterology, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA
Clin Gastroenterol Hepatol 6:443-50. 2008..This study investigated the use of patient navigation within an open-access referral system and its effects on colonoscopy completion rates among urban minorities...
Sociodemographic correlates of stage of adoption for colorectal cancer screening in African AmericansJennifer Christie
Emory University School of Medicine, Department of Medicine, Atlanta, GA 30322, USA
Ethn Dis 19:323-9. 2009..Endoscopic screening, while effective in reducing both, is greatly underutilized. This research sought to understand sociodemographic factors related to stage of readiness for endoscopic screening...
Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillanceRobert Goldstone
Department of Medicine, Division of Gastroenterology, Mount Sinai School of Medicine, New York, New York 10029, USA
Inflamm Bowel Dis 18:832-7. 2012..The aim was to determine whether a difference exists in the anatomic distribution of dysplasia discovered in UC patients undergoing colonoscopic surveillance...
An examination of the psychosocial factors influencing colorectal cancer patients' communication of colorectal cancer patient risk with their siblingsCatalina Lawsin
Department of Psychology, B 8 215 Baruch College, City University of New York, One Bernard Baruch Way, New York, NY 10010, USA
Cancer Epidemiol Biomarkers Prev 18:2907-12. 2009....
Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurineSierra Matula
Dr. Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA
Clin Gastroenterol Hepatol 3:1015-21. 2005..Importantly, the use of 6MP/AZA did not increase malignant transformation in UC...
Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitisThomas Ullman
Department of Medicine, The Dr Henry D Janowitz Division of Gastroenterology, Box 1069, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA
Gastroenterology 125:1311-9. 2003....
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trialJames F Marion
Mount Sinai School of Medicine, New York, New York 10028 0517, USA
Am J Gastroenterol 103:2342-9. 2008..We prospectively compared dye-spray technique using methylene blue to standard colonoscopic surveillance in detecting dysplasia...
Barriers to colorectal cancer screening: inadequate knowledge by physiciansMelissa Gennarelli
Derald H. Ruttenberg Cancer Center, Mount Sinai School of Medicine, One East 100th Street, New York, NY 10029, USA
Mt Sinai J Med 72:36-44. 2005..Lack of knowledge about CRC is one barrier to screening that may contribute to underutilization of screening for minority populations. Further educational efforts should be targeted to these health care professionals...
Progression of low-grade dysplasia in ulcerative colitis: effect of colonic locationRobert Goldstone
The Dr Henry D Janowitz Division of Gastroenterology, The Mount Sinai School of Medicine, New York, New York 10029, USA
Gastrointest Endosc 74:1087-93. 2011..Emerging evidence suggests that the biology of sporadic colorectal neoplasia may differ between the proximal and distal colon. Whether such a difference exists in colitis-associated colorectal neoplasia is unknown...
Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathwaysXianyang Yio
Division of Gastroenterology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA
Gastroenterology 130:1696-706. 2006..These site-directed mutagenesis experiments provide the tools for continued probing of signal transduction mechanisms and structural elements responsible for TFF1 functions...
Predictors of endoscopy in minority womenJennifer Christie
Division of Gastroenterology, Mount Sinai School of Medicine New York, NY 10029, USA
J Natl Med Assoc 97:1361-8. 2005..This study evaluates the association between socioeconomic, medical and psychosocial factors and the use of endoscopy in low-income minority women...
Trefoil factor family-3 is associated with aggressive behavior of colon cancer cellsXianyang Yio
The Dr Henry D Janowitz Division of Gastroenterology, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
Clin Exp Metastasis 22:157-65. 2005..The present study was conducted to determine whether TFF3 expression contributes to the malignant behavior of cancer cells in vitro and in vivo...
Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control studyInga Peter
Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029 USA
BMC Med Genet 12:63. 2011..We evaluated a set of well-established CD-susceptibility variants to determine if they can explain the increased CD risk in the AJ population...
Chemoprevention of colorectal cancer in ulcerative colitisVictoria J Croog
Dr. Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA
Int J Colorectal Dis 18:392-400. 2003..Evidence suggests, but does not prove, that folic acid is chemopreventive in patients with UC. Further studies are needed to fully define the chemoprotective role of these and other agents...
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumorsMasayuki Fukata
Inflammatory Bowel Disease Center, Mount Sinai School of Medicine, New York, New York, USA
Gastroenterology 133:1869-81. 2007..The molecular mechanisms linking inflammation and colon carcinogenesis are incompletely understood. We tested the hypothesis that Toll-like receptor 4 (TLR4) is involved in tumorigenesis in the setting of chronic inflammation...
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk populationThomas F Imperiale
Department of Medicine, Indiana University, and the Regenstrief Institute, Indianapolis, IN 46202, USA
N Engl J Med 351:2704-14. 2004....
Teaching clinical management skills for genetic testing of hereditary nonpolyposis colorectal cancer using a Web-based tutorialKathleen Barnes
Department of Human Genetics, Mount Sinai School of Medicine, New York, New York 10029, USA
Genet Med 5:43-8. 2003..001). CONCLUSIONS: Supplementing written materials with an interactive program may assist medical professionals in integrating their knowledge of HNPCC and genetic testing into clinical practice...
Short-chain fatty acid induces intestinal mucosal injury in newborn rats and down-regulates intestinal trefoil factor gene expression in vivo and in vitroJing Lin
Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
J Pediatr Gastroenterol Nutr 41:607-11. 2005..Intestinal trefoil factor (ITF) is a factor important for the maintenance and repair of the intestinal mucosal barrier. Regulation of ITF gene expression by SCFAs may be involved as one of the mechanisms...
Distress among inflammatory bowel disease patients at high risk for colorectal cancer: a preliminary investigation of the effects of family history of cancer, disease duration, and perceived social supportChristine Rini
Department of Oncological Sciences, Mount Sinai School of Medicine, New York, New York, USA
Psychooncology 17:354-62. 2008..02). Having a DR history of CRC also predicted higher CRC-specific distress, but only among patients diagnosed more recently (p = 0.03). Clinical implications of these findings are discussed along with future research directions...
Intestinal trefoil factor: a marker of poor prognosis in gastric carcinomaTakasuke Yamachika
Gastrointestinal Research Laboratory, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA
Clin Cancer Res 8:1092-9. 2002..Gastric adenocarcinomas can arise through a process of intestinalization, but no study has yet comprehensively examined the expression of ITF in gastric cancer or correlated ITF expression with clinical outcome in any cancer type...
Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumorsThomas Curran
Division of Gastroenterology, Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA
Pancreas 40:1253-7. 2011..Neuroendocrine tumors demonstrate heterogeneous behavior based on the site of origin and histology. This study aimed to delineate prognostic clinicopathologic features in patients with metastatic midgut carcinoid...
Cancer in inflammatory bowel diseaseJianlin Xie
GI Division, Mount Sinai School of Medicine, One Gustave Levy Place, New York City, NY 10029, USA
World J Gastroenterol 14:378-89. 2008..New endoscopic and molecular screening approaches may further refine our current surveillance guidelines and our understanding of the natural history of dysplasia...
The diagnosis and treatment of pouchitis in inflammatory bowel diseaseAdam Cheifetz
Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029-6574, USA
J Clin Gastroenterol 38:S44-50. 2004..Hopefully, this will also bring more clarity to the heterogeneous population of patients with pouchitis and allow for more focused therapeutic strategies...
Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterologyShivani Batra
Department of Human Genetics, Mount Sinai School of Medicine, New York, New York 10029, USA
Am J Gastroenterol 97:729-33. 2002..However, there is a need for physician education regarding the recognition of pedigrees consistent with inherited colorectal cancer, the genetic counseling process, and the availability of mutation testing for FAP and HNPCC...
Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinicLina Jandorf
Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA
J Urban Health 82:216-24. 2005..1% vs. 25%, P=.086). Thus, a PN system successfully increases CRC screening rates among a predominantly minority population of low socioeconomic status...
The molecular and genetic basis of colon cancerDavid H Robbins
Dr. Henry D. Janowitz Division of Gastroenterology, Box 1069, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA
Med Clin North Am 86:1467-95. 2002..It is hoped that such progress will impact on the frequency and mortality of this very common and frequently fatal cancer...
Practical advances in stool screening for colorectal cancerJonathan Potack
The Dr Henry D Janowitz Division of Gastroenterology, Mount Sinai School of Medicine, New York, New York 10029, USA
J Natl Compr Canc Netw 8:81-92. 2010..As the performance characteristics for FIT and stool DNA tests continue to evolve, stool-based testing for CRC is expected to become a more reliable component in the armamentarium for CRC screening...
Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancerCatalina Lawsin
Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA
Support Care Cancer 15:557-64. 2007..This study examined correlates of CAM use among colorectal cancer (CRC) survivors, an understudied population that experiences many physical and psychological difficulties...
Pathology of mouse models of intestinal cancer: consensus report and recommendationsGregory P Boivin
Department of Pathology and Laboratory Medicine, University of Cincinnati and Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio 45267, USA
Gastroenterology 124:762-77. 2003
Research Grants
- TFF3 GENE EXPRESSION IN METASTATIC COLON CANCERSteven Itzkowitz; Fiscal Year: 2001..The use of the TFF3 gene to drive expression of suicide genes offers a novel approach which should result in more targetted, safer gene therapy for metastatic colon cancer. ..
- Trefoil Factors in GI Cancer BiologySteven Itzkowitz; Fiscal Year: 2007..The results of these studies could provide insights into novel treatment strategies for gastrointestinal malignancies. ..
- Trefoil Factors in GI Cancer BiologySteven Itzkowitz; Fiscal Year: 2009..The results of these studies could provide insights into novel treatment strategies for gastrointestinal malignancies. ..
- Trefoil Factors in GI Cancer BiologySteven H Itzkowitz; Fiscal Year: 2010..The results of these studies could provide insights into novel treatment strategies for gastrointestinal malignancies. ..
